- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06131541
Ridge Splitting With Implant Placement Using Autogenous Tooth Graft
Alveolar Ridge Splitting With Simultaneous Implant Placement Using Undemineralized Autogenous Tooth Graft: a Randomized Clinical Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
In cases of a narrow ridge, the alveolar ridge expansion technique by means of hand osteotomes with gradually increasing dimensions was introduced by Tatum and modified by Summers and it can be used regardless of the bone quality.
Searching for absolute biocompatible material and taking into account the features of the enamel and dentin, using the tooth as an autologous grafting material was first advocated. Tooth and bone are sharing many characteristics, which supports the idea that tooth could be used as a grafting material. In fact, hydroxyapatite crystals make up the tooth inorganic composition (65%). Moreover, Collagen (mostly type I) and non-collagenic proteins comprised up the tooth organic component (35%). In addition, because autologous tooth graft (ATG) is denser than bone, minimal resorption rates were found to be advantageous to autobone. For the purpose of employing ATG as a grafting material, various methods and techniques have been suggested for developing undemineralized, demineralized or partially demineralized ATG.The outcomes of utilizing undemineralized autologous tooth graft (UATG) around SDIP following RSEA have not yet been evaluated. Therefore, the current trial aimed to assess the clinical and radiological performances of UATG for the treatment of horizontal alveolar ridge deficiencies using RSEA with SDIP.
The aim of this study is to evaluate the radiographic and the clinical outcomes of application of the alveolar ridge splitting (ARS) in combination with ATG, associated with immediate implant placement versus ARS in combination with autogenous bone graft, associated with immediate implant placement in patients with horizontal bony insufficiency of alveolar ridges.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kafrelsheikh
-
Kafr Ash Shaykh, Kafrelsheikh, Egypt, 214312
- faculty of dentistry, kafrelsheikh University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Good general health at the time of surgery
- At least 3 months of healing after tooth extraction
- Horizontally compromised alveolar ridges at least 10 mm high and 3 mm wide.
Exclusion Criteria:
- A vertical bone defect in the edentulous ridge;
- Thick cortex in the labial/buccal with less cancellous bone inside;
- Obvious undercut on the labial/buccal side;
- Uncontrolled periodontal conditions or other oral disorders;
- A history of radiotherapy in the head and neck region
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group I: autogenous bone graft group
11 subjects will be assigned to receive alveolar ridge splitting in combination with autogenous bone graft associated with immediate implant placement
|
autogenous bone graft will augment the gap between the splitted ridge and the simultaneously [laced implant fixture
|
|
Experimental: Group II: autogenous tooth graft group
11 subjects will be assigned to receive alveolar ridge splitting in combination with undemineralized autogenous tooth graft associated with immediate implant placement
|
undemineralized autogenous tooth graft will augment the gap between the splitted ridge and the simultaneously [laced implant fixture
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stability Quotient of Implants (SQI)
Time Frame: 12-month.
|
The implant stability was recorded using Osstell TM.
Following implant insertion, SQI readings were taken immediately, then again after six and twelve months.
|
12-month.
|
|
Horizontal bone dimensions (HBDs)
Time Frame: 12 months
|
The HBD alterations were assessed by measuring horizontal spacing between the external edges of labial and palatal bony plates at a level 2mm apical of the fixture platform.
|
12 months
|
|
Peri-implant Bone Density (PBD)
Time Frame: 12 months
|
For consistent measurement of the PBD, 1-mm-diameter Region of interest (RI) was selected and traced 1.2 mm distant from the fixture on the cross-sectional slices followed by counting the threshold pixels inside the RI.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pink esthetic score (PES)
Time Frame: 12 months
|
Digital intraoral scannings were gathered before surgery, at 6 and 12-months after implantation, to evaluate the PES changes.
Seven variables were assessed in relation to a nearby reference teeth: mesial and distal papilla, soft tissue level, colour, texture and shape, and alveolar bone defects.
14 is the maximum possible value for PES.
Scoring each parameter on a 0-2 scale: 0 is the minimum score and 2 is the maximum.
|
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: WAlid AH Elamrousy, Ph.D, Kafrelsheikh University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KFSIRB200-80
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peri-Implantitis
-
University of ManitobaUnknownPeri ImplantitisCanada
-
Istanbul Medipol University HospitalAnkara University; Ankara Medipol University; Lokman Hekim UniversityCompletedPeri Implantitis | Peri-Implant Health | Peri Implant MucositisTurkey (Türkiye)
-
PolyPid Ltd.MIS Implant Technologies, LtdCompleted
-
King Abdullah University HospitalJordan University of Science and TechnologyCompletedPeri-Implantitis and Peri-implant MucositisJordan
-
University of PittsburghRecruiting
-
Research Centre for Medical Genetics, Russian FederationCompleted
-
University of ValenciaCompletedEarly Apical Peri-implantitis
-
Rambam Health Care CampusCompletedDental Implants,Peri-implantitis,SmokingIsrael
-
King's College LondonNot yet recruiting
Clinical Trials on autogenous bone graft
-
Cairo UniversityRecruitingIntrabony Periodontal DefectEgypt
-
Kafrelsheikh UniversityCompleted
-
Spine WaveTerminatedDegenerative Disc Disease | Spondylolisthesis | StenosisUnited States
-
Ain Shams UniversityCompletedImmediate Implant PlacementEgypt
-
Cairo UniversityNot yet recruiting
-
Haifaa Mohammed Al-hussiniActive, not recruitingAlveolar Bone Grafting | Bone Regeneration Following Wisdom Teeth Extraction | Tooth Extraction Site HealingYemen
-
Ferring PharmaceuticalsCompletedArthrodesis Surgery Involving the Hindfoot or AnkleUnited States, Canada
-
University of ZurichCompleted
-
Semmelweis UniversityEnrolling by invitation
-
Medtronic Spinal and BiologicsAverion International Corporation; Baim Institute for Clinical ResearchWithdrawnAlveolar Bone Loss in Mandible | Edentulous Alveolar Ridge In Mandible